A shadow economy for unapproved slimming drugs is being driven by social media fitness personalities and vendors on communication apps, according to recent findings.
Investigational Drug Gaining Traction Online
Retatrutide, which is still in research studies, is being promoted by social media influencers for its supposed weight-reducing effects. Viewers are encouraged to contact these profiles directly for supplier links, while also receiving promotional offers.
Active Trade on Social Networks
Additionally, a robust market exists on Telegram, where groups with thousands of participants share “before and after” photos, injection guides and assertions of rapid British shipping. Sellers promote the substance there before directing buyers to other platforms for purchases.
Understanding The Experimental Drug
Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic.
Medical Experts Express Worries
However, doctors and chemists have cautions that the distribution of what is still an unlicensed medication in the UK is a cause for concern and could lead to users injecting substances of uncertain source.
Some experts said the popularity for retatrutide could be connected to the increasing price of licensed weight loss products such as Mounjaro.
Legal Status and Implementation
Selling retatrutide on social media or Telegram is illegal in the UK, as it is an unapproved medication that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Some content creators try to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still violate medicines, advertising, and consumer regulations, risking penalties, prosecution or prison.
Platform Reaction and Material Removal
Based on the social media company, the service has removed violative content and prohibited associated hashtags and query recommendations. The organization said it was committed to maintaining the service secure and allocating resources in enhancing enforcement strategies.
Online Trading Operations
Investigations also discovered groups with up to 9,000 members selling the experimental drug using Telegram's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” immediately displays groups with numerous of members, filled with photos of weight loss, positive reviews and detailed instructions for preparing or injecting at residence.
After moments of joining one community, a vendor posted WhatsApp details, where most purchases occur. The seller provided an instruction manual and guaranteed delivery within two days. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one asked about weight, health issues or past usage.
Product Information and Pricing
Inside these groups, posts display black plastic parcels with postal service stickers, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at residence with purified liquid, or ready-to-use injectors typically priced at 160 pounds for 20 milligrams. When asked how much time a pen should last, sellers give contradictory answers ranging from a few weeks to “depends on your body”.
Service Moderation and Security Actions
A spokesperson for the messaging service said it actively monitored harmful material on its service including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are administering materials they cannot confirm. Although the research behind retatrutide is valid, these online products may not include what they claim,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor linked the surge in interest to current cost increases for approved slimming medications such as Mounjaro. “With costs rising, patients are turning to social media. But counterfeit injections are highly risky. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she said.
Her team has already seen individuals harmed by self-injection from unconfirmed suppliers. “We understand the disappointment, but buying from Telegram or WhatsApp is gambling with your health,” said the doctor. “These substances could be impure or incorrectly dosed.”
Producer Statement
A spokesperson from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been evaluated or approved by any government authority globally. “Therefore at this time no one can sell [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a company investigational substance not yet approved … may subject patients to possibly serious health risks”.
